Infusion Product TNFα, Th2, and STAT3 Activities are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy

Nowicki TS, Peters CW, Quiros C, Kidd CK, Kawakami M, Klomhaus AM, Baselga-Carretero I, Kaplan-Lefko P, Macabali MH, Perez Garcilazo I, Berent-Maoz B, Comin-Anduix B, Ribas A. Infusion Product TNFα, Th2, and STAT3 Activities are Associated with Clinical Responses to Transgenic T-cell Receptor Cell Therapy. Cancer Immunol Res. 2023 Oct 23. doi: 10.1158/2326-6066.CIR-23-0577. Epub ahead of print. PMID: 37871333.


Related Posts